User: Guest  Login
Title:

Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset-Lessons Learned.

Document type:
Article; Journal Article
Author(s):
Dölken, Lars; Stich, August; Spinner, Christoph D
Abstract:
After more than one year of the COVID-19 pandemic, antiviral treatment options against SARS-CoV-2 are still severely limited. High hopes that had initially been placed on antiviral drugs like remdesivir have so far not been fulfilled. While individual case reports provide striking evidence for the clinical efficacy of remdesivir in the right clinical settings, major trials failed to demonstrate this. Here, we highlight and discuss the key findings of these studies and underlying reasons for thei...     »
Journal title abbreviation:
Viruses
Year:
2021
Journal volume:
13
Journal issue:
6
Fulltext / DOI:
doi:10.3390/v13060963
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/34067381
Print-ISSN:
1999-4915
TUM Institution:
II. Medizinische Klinik und Poliklinik (Gastroenterologie)
 BibTeX